Gene editing takes a major step toward ending daily cholesterol pills
New therapy targets the liver’s PCSK9 gene to lower cholesterol. Depositphotos – By Bronwyn Thompson 2026 Jan 25 – A new CRISPR-based one-off procedure that lowers “bad” cholesterol has been approved to enter Phase I human trial. If successful, it could be the first …